Tag Archives: randomized trial
Semaglutide in HIV: 108 Participants, 32 Weeks
Semaglutide did not change the trial's measured vascular markers over 32 weeks, while ASCVD risk score and hsCRP differed from placebo.
No account yet?
Create an AccountJoin the list for batch updates and new compound announcements. We will send you a single-use 8% code once you confirm your address.
Every batch is tested separately
Purity is measured per production lot, not once per product.
See the batch records